Possia
Withdrawn
This medicine's authorisation has been withdrawn
ticagrelor
MedicineHumanWithdrawn
- Application under evaluation
- CHMP opinion
- European Commission decision
Overview
The marketing authorisation for Possia has been withdrawn at the request of the marketing-authorisation holder.
Possia : EPAR - Summary for the public
English (EN) (198.52 KB - PDF)
First published: Last updated:
български (BG) (693.72 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
español (ES) (200.71 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
čeština (CS) (249.25 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
dansk (DA) (278.34 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Deutsch (DE) (338.67 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
eesti keel (ET) (200.98 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
ελληνικά (EL) (285.03 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
français (FR) (263 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
italiano (IT) (202.23 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
latviešu valoda (LV) (313.57 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
lietuvių kalba (LT) (229.54 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
magyar (HU) (303.85 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Malti (MT) (248.52 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Nederlands (NL) (260.43 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
polski (PL) (250.23 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
português (PT) (201.13 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
română (RO) (230.06 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
slovenčina (SK) (307.1 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
slovenščina (SL) (240.57 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Suomi (FI) (201.24 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
svenska (SV) (198.69 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Product information
Possia : EPAR - Product Information
English (EN) (805.47 KB - PDF)
First published: Last updated:
български (BG) (1.27 MB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
español (ES) (722.27 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
čeština (CS) (955.11 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
dansk (DA) (624.97 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
Deutsch (DE) (718.62 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
eesti keel (ET) (734.64 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
ελληνικά (EL) (1.26 MB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
français (FR) (757.4 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
íslenska (IS) (626.98 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
italiano (IT) (709.78 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
latviešu valoda (LV) (1.05 MB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
lietuvių kalba (LT) (760.99 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
magyar (HU) (959.74 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
Malti (MT) (868.76 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
Nederlands (NL) (721.11 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
norsk (NO) (628.65 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
polski (PL) (1.36 MB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
português (PT) (1.03 MB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
română (RO) (794.52 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
slovenčina (SK) (987.96 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
slovenščina (SL) (953.01 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
Suomi (FI) (656.85 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
svenska (SV) (637.11 KB - PDF)
First published: 07/01/2011Last updated: 01/02/2013
Latest procedure affecting product information:
WS/0292
24/10/2012
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
Possia : EPAR - All Authorised presentations
English (EN) (548.06 KB - PDF)
First published: Last updated:
български (BG) (617.58 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
español (ES) (573.16 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
čeština (CS) (563.56 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
dansk (DA) (575.82 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Deutsch (DE) (557.18 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
eesti keel (ET) (558 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
ελληνικά (EL) (954.96 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
français (FR) (587.04 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
íslenska (IS) (549.89 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
italiano (IT) (584.58 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
latviešu valoda (LV) (611.74 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
lietuvių kalba (LT) (572.93 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
magyar (HU) (591.4 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Malti (MT) (572.61 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Nederlands (NL) (548.36 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
norsk (NO) (586.22 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
polski (PL) (600.78 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
português (PT) (574.41 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
română (RO) (609.93 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
slovenčina (SK) (569.01 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
slovenščina (SL) (553.5 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Suomi (FI) (578.65 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
svenska (SV) (575.55 KB - PDF)
First published: 07/01/2011Last updated: 07/01/2011
Product details
- Name of medicine
- Possia
- Active substance
- Ticagrelor
- International non-proprietary name (INN) or common name
- ticagrelor
- Therapeutic area (MeSH)
- Peripheral Vascular Diseases
- Acute Coronary Syndrome
- Anatomical therapeutic chemical (ATC) code
- B01AC24
Pharmacotherapeutic group
Antithrombotic agentsTherapeutic indication
Possia, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non-ST-elevation myocardial infarction [NSTEMI] or ST-elevation myocardial infarction [STEMI]); including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).
Authorisation details
- EMA product number
- EMEA/H/C/002303
- Marketing authorisation holder
- AstraZeneca AB
Gärtunavägen
151 85 Södertälje
Sweden - Marketing authorisation issued
- 03/12/2010
- Revision
- 2
Assessment history
Possia : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (238.95 KB - PDF)
First published: Last updated:
More information on Possia
Public statement on Possia: Withdrawal of the marketing authorisation in the European Union
Reference Number: EMA/212211/2013
English (EN) (57.49 KB - PDF)
First published: Last updated:
This page was last updated on